|
|
| RAC December 13, 2005 - Presentation Materials |
|
| 102nd Meeting - Day One |
| Bethesda, Maryland |
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
Call to Order and Opening Remarks |
|
|
| |
Diane Wara, M.D., Chair, NIH RAC |
|
|
| |
Webcast
|
|
| |
|
|
|
Minutes of the September 21, 2005, RAC Meeting |
|
|
| |
RAC Reviewers: Naomi Rosenberg, Ph.D. and Nikunj Somia, Ph.D. |
|
|
| |
Webcast
|
|
| |
|
|
|
Gene Transfer Safety Assessment Board Report |
|
|
| |
RAC Reviewers: Steven Albelda, M.D., Helen Heslop, M.D., Howard Federoff, M.D., Ph.D., and Diane Wara, M.D. |
|
|
| |
Webcast
|
|
| |
|
|
|
Risk-Benefit Assessment in Early-Phase Pediatric Research |
|
|
| |
Gilman Grave, M.D., National Institute of Child Health and
Human Development, National Institutes of Health, Bethesda, MD |
|
|
| |
Slides
Webcast
|
|
| |
|
|
|
|
Discussion of Human Gene Transfer Protocol #0510-740 |
|
|
| |
A Phase I Safety Study in Subjects with Leber Congenital Amaurosis (LCA) Using Adeno-Associated Viral Vector to Deliver the Gene for Human RPE65 into the Retinal Pigment Epithelium (RPE) |
|
|
| |
Albert M. Maguire, M.D., Scheie Eye Institute, University of Pennsylvania Health System, Philadelphia, PA |
|
|
| |
Slides
Webcast
|
|
| |
|
|
|
|
Discussion of Human Gene Transfer Protocol #0510-732 |
|
|
| |
A Phase I/IIA Dose-Escalation Trial of Intratumoral Injection with Oncolytic Adenovirus Vector INGN 007 (VRX-007) in Patients with Advanced Solid Tumors |
|
|
| |
John Nemunaitis, M.D., Mary Crowley Medical Research Center,
Dallas, TX |
|
|
| |
Slides
Webcast
|
|
| |
|
|
|
|
Discussion of Human Gene Transfer Protocol #0510-734 |
|
|
| |
An Open-Label, Phase I, Dose-Escalation Study of AD-EGFR-CD533 and Surgery for Patients with Resectable Recurrent High-Grade Glioma |
|
|
| |
William C. Broaddus, M.D., Ph.D., Virginia Commonwealth University Medical Center, Richmond, VA |
|
|
| |
Theodore D. Chung, M.D., Ph.D., Virginia Commonwealth University Medical Center, Richmond, VA |
|
|
| |
Slides
Webcast
|
|
| |
|
|
|
ADJOURN |
|
| |
|
Top of Page |
|
|
|
